Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adhesion and cell division protein A (AdvA) is an essential protein in Streptococcus pyogenes (Group A Streptococcus) that is vital for cell viability and proper division (Beilharz et al., 2012). It is primarily involved in coordinating the assembly of the cell division machinery at the septum, specifically influencing Z-ring formation and chromosome segregation (UniProt Q9A144). AdvA is highly conserved among pyogenic streptococci but lacks close homologs in humans, making it an attractive candidate for the development of novel antimicrobial agents (PubMed PMID: 22493205). Research indicates that depletion of AdvA leads to severe defects in cell morphology, including filamentation and impaired DNA distribution, ultimately resulting in bacterial death. As S. pyogenes is responsible for a wide range of human diseases from pharyngitis to life-threatening necrotizing fasciitis, targeting AdvA offers a potential strategy to combat antibiotic-resistant strains.
Inhibition of bacterial cell division by disrupting septum formation and Z-ring assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adhesion and cell division protein A (AdvA).